H2 Investment Life Sciences Uptick Anticipated But Markets Remain Enduringly Cautious
Post-Election Continuum For UK Life Sciences Favored Over Radical Change
Taylor Wessing investment partners share their thoughts about market trends, the surge in AI interest and the new UK government’s approach to the life sciences agenda.
